v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income / (loss)
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2023   968        
Beginning balance at Dec. 31, 2023 $ 9,141 $ 1 $ 27,695 $ (18,558) $ 3 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital stock issuance (in shares)   26        
Capital stock issuance 1   1      
Stock-based compensation 374   374      
Other comprehensive (loss) income (1)       (1)  
Net (loss) income (1,446)     (1,446)    
Ending balance (in shares) at Mar. 31, 2024   994        
Ending balance at Mar. 31, 2024 8,069 $ 1 28,070 (20,004) 2 0
Beginning balance (in shares) at Dec. 31, 2023   968        
Beginning balance at Dec. 31, 2023 9,141 $ 1 27,695 (18,558) 3 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive (loss) income (4)          
Net (loss) income (2,903)          
Ending balance (in shares) at Jun. 30, 2024   1,008        
Ending balance at Jun. 30, 2024 6,818 $ 1 28,279 (21,461) (1) 0
Beginning balance (in shares) at Mar. 31, 2024   994        
Beginning balance at Mar. 31, 2024 8,069 $ 1 28,070 (20,004) 2 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital stock issuance (in shares)   14        
Capital stock issuance 31   31      
Stock-based compensation 178   178      
Other comprehensive (loss) income (3)       (3)  
Net (loss) income (1,457)     (1,457)    
Ending balance (in shares) at Jun. 30, 2024   1,008        
Ending balance at Jun. 30, 2024 $ 6,818 $ 1 28,279 (21,461) (1) 0
Beginning balance (in shares) at Dec. 31, 2024 1,131 1,131        
Beginning balance at Dec. 31, 2024 $ 6,562 $ 1 29,866 (23,305) (4) 4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital stock issuance (in shares)   15        
Capital stock issuance 2   2      
Stock-based compensation 204   204      
Other comprehensive (loss) income 3       3  
Net (loss) income (541)     (545)   4
Ending balance (in shares) at Mar. 31, 2025   1,146        
Ending balance at Mar. 31, 2025 $ 6,230 $ 1 30,072 (23,850) (1) 8
Beginning balance (in shares) at Dec. 31, 2024 1,131 1,131        
Beginning balance at Dec. 31, 2024 $ 6,562 $ 1 29,866 (23,305) (4) 4
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive (loss) income 11          
Net (loss) income $ (1,656)          
Ending balance (in shares) at Jun. 30, 2025 1,214 1,214        
Ending balance at Jun. 30, 2025 $ 6,079 $ 1 31,028 (24,967) 6 11
Beginning balance (in shares) at Mar. 31, 2025   1,146        
Beginning balance at Mar. 31, 2025 6,230 $ 1 30,072 (23,850) (1) 8
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Capital stock issuance (in shares)   52        
Capital stock issuance $ 745   745      
Capital stock issuance including employee stock purchase plan (in shares) 16          
Capital stock issuance including employee stock purchase plan $ 33          
Stock-based compensation 178   178      
Other comprehensive (loss) income 8       7 1
Net (loss) income $ (1,115)     (1,117)   2
Ending balance (in shares) at Jun. 30, 2025 1,214 1,214        
Ending balance at Jun. 30, 2025 $ 6,079 $ 1 $ 31,028 $ (24,967) $ 6 $ 11